MEDIFAST INC Valuation
| MED Stock | USD 19.84 0.17 0.86% |
At this time, the firm appears to be undervalued. MEDIFAST INC secures a last-minute Real Value of $34.13 per share. The latest price of the firm is $19.84. Our model forecasts the value of MEDIFAST INC from examining the firm fundamentals such as profit margin of 0.01 %, and Return On Equity of 0.0366 as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting MEDIFAST INC's valuation include:
Price Book 1.0376 | Enterprise Value 62.8 M | Enterprise Value Ebitda 2.6483 | Price Sales 0.319 | Trailing PE 29.3582 |
Undervalued
Today
Please note that MEDIFAST INC's price fluctuation is very steady at this time. Calculation of the real value of MEDIFAST INC is based on 3 months time horizon. Increasing MEDIFAST INC's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the MEDIFAST stock is determined by what a typical buyer is willing to pay for full or partial control of MEDIFAST INC. Since MEDIFAST INC is currently traded on the exchange, buyers and sellers on that exchange determine the market value of MEDIFAST Stock. However, MEDIFAST INC's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 19.84 | Real 34.13 | Target 81.0 | Hype 19.6 | Naive 19.64 |
The real value of MEDIFAST Stock, also known as its intrinsic value, is the underlying worth of MEDIFAST INC Company, which is reflected in its stock price. It is based on MEDIFAST INC's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of MEDIFAST INC's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of MEDIFAST INC helps investors to forecast how MEDIFAST stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MEDIFAST INC more accurately as focusing exclusively on MEDIFAST INC's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use MEDIFAST INC's intrinsic value based on its ongoing forecasts of MEDIFAST INC's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against MEDIFAST INC's closest peers. If more than one evaluation category is relevant for MEDIFAST INC we suggest using both methods to arrive at a better estimate.
MEDIFAST INC Cash |
|
MEDIFAST Valuation Trend
Comparing MEDIFAST INC's enterprise value against its market capitalization is a good way to estimate the value of MEDIFAST INC uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
MEDIFAST Revenue by Product
MEDIFAST INC Total Value Analysis
MEDIFAST INC is now forecasted to have company total value of 62.82 M with market capitalization of 215.15 M, debt of 22.01 M, and cash on hands of 87.69 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the MEDIFAST INC fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
62.82 M | 215.15 M | 22.01 M | 87.69 M |
MEDIFAST INC Investor Information
About 86.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.04. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. MEDIFAST INC has Price/Earnings To Growth (PEG) ratio of 1.95. The entity last dividend was issued on the 18th of September 2023. The firm had 1:20 split on the February 14, 2011. Based on the measurements of operating efficiency obtained from MEDIFAST INC's historical financial statements, MEDIFAST INC is performing exceptionally good at this time. It has a great probability to report excellent financial results in January.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.12 | 0.1179 |
|
| |||||
| Operating Income | 132.7 M | 126.4 M |
|
|
MEDIFAST INC Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. MEDIFAST INC has an asset utilization ratio of 345.93 percent. This indicates that the Company is making $3.46 for each dollar of assets. An increasing asset utilization means that MEDIFAST INC is more efficient with each dollar of assets it utilizes for everyday operations.MEDIFAST INC Ownership Allocation
The market capitalization of MEDIFAST INC is $215.15 Million. The majority of MEDIFAST INC outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in MEDIFAST INC to benefit from reduced commissions. Thereupon, institutional holders are subject to a different set of regulations than regular investors in MEDIFAST INC. Please pay attention to any change in the institutional holdings of MEDIFAST INC as this could imply that something significant has changed or is about to change at the company. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.MEDIFAST INC Profitability Analysis
The company reported the last year's revenue of 1.07 B. Total Income to common stockholders was 99.42 M with profit before taxes, overhead, and interest of 1.14 B.MEDIFAST INC Past Distributions to stockholders
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates MEDIFAST INC's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in MEDIFAST INC and how it compares across the competition.
About MEDIFAST INC Valuation
The stock valuation mechanism determines MEDIFAST INC's current worth on a weekly basis. Our valuation model uses a comparative analysis of MEDIFAST INC. We calculate exposure to MEDIFAST INC's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of MEDIFAST INC's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 775.9 M | 814.6 M | |
| Pretax Profit Margin | 0.12 | 0.13 | |
| Operating Profit Margin | 0.12 | 0.12 | |
| Net Profit Margin | 0.09 | 0.10 | |
| Gross Profit Margin | 0.72 | 0.54 |
A single share of MEDIFAST INC represents a small ownership stake in the entity. As a stockholder of MEDIFAST, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
MEDIFAST INC Dividends Analysis For Valuation
At present, MEDIFAST INC's Dividend Yield is projected to increase slightly based on the last few years of reporting. The current year's Dividend Payout Ratio is expected to grow to 0.77, whereas Dividend Paid And Capex Coverage Ratio is forecasted to decline to 1.14. . At present, MEDIFAST INC's Earnings Yield is projected to increase slightly based on the last few years of reporting.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 73 M | 76.7 M | |
| Dividend Yield | 0.10 | 0.10 | |
| Dividend Payout Ratio | 0.73 | 0.77 | |
| Dividend Paid And Capex Coverage Ratio | 1.86 | 1.14 |
There are various types of dividends MEDIFAST INC can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of MEDIFAST shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from MEDIFAST INC directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When MEDIFAST pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of MEDIFAST INC by the value of the dividends paid out.
MEDIFAST INC Growth Indicators
Investing in growth stocks can be very risky. If the company such as MEDIFAST INC does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 10.9 M | |
| Quarterly Earnings Growth Y O Y | -0.953 |
MEDIFAST INC Current Valuation Indicators
Valuation refers to the process of determining the present value of MEDIFAST INC and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value MEDIFAST we look at many different elements of the entity such as MEDIFAST's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as MEDIFAST INC, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use MEDIFAST INC's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes MEDIFAST INC's worth.Complementary Tools for MEDIFAST Stock analysis
When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Global Correlations Find global opportunities by holding instruments from different markets |